A Founder’s Contract Becomes a Deal-Breaker
Charlotte Tilbury’s attempt to renegotiate her contract with Puig has unexpectedly become a central obstacle in the proposed Puig Estée Lauder deal. Puig, which took a majority stake in the Charlotte Tilbury brand in 2020 and now owns 78.5 percent, is in advanced merger talks with Estée Lauder Companies. But Expansión reports that Tilbury, who still owns a significant minority stake, is unhappy with how her existing earn-out structure is playing out. The current agreement links future payouts and final valuation to the brand’s performance through 2031, including staged call and put options. As merger discussions intensify, Tilbury is reportedly seeking improved terms, arguing that the current performance-based triggers will yield no earn-out. Her move underscores how a single founder contract can exert disproportionate influence over a multibillion-dollar beauty brand acquisition.
Inside the Earn-Out: How Tilbury’s Payout Is Structured
At the heart of the dispute is an intricate package of earn-outs, call and put options, and a change-of-control clause. Puig’s deal with Charlotte Tilbury includes deferred payments tied to revenue and profitability targets, a classic earn-out design intended to keep founders focused on growth. Market sources cited by Expansión suggest that, based on current business performance, those targets would not trigger any earn-out payment for Tilbury, leaving much of her upside unrealised. The contract also grants Puig the right to progressively acquire 100 percent ownership between 2026 and 2031 at valuations linked to financial performance. This structure mirrors Puig’s wider acquisition playbook for founder-led brands, balancing control with ongoing founder involvement. Now, Tilbury is reportedly pressing to rebase or reshape those triggers, seeking a more favourable conversion of her minority stake as strategic options for the brand are being reconsidered.
The Change-of-Control Clause Estée Lauder Does Not Want
Complicating the Charlotte Tilbury merger dynamics is a change-of-control clause that could be activated if Puig merges or changes ownership. According to reports, this provision gives Charlotte Tilbury the right to force a sale of her entire minority stake if such a transaction occurs. For any potential partner, including Estée Lauder, that clause represents a sizeable contingent liability: a mandatory payout to the founder that could reach several hundred million euros, depending on performance metrics at the time. Expansión notes that Estée Lauder is not willing to absorb that obligation, effectively turning Tilbury’s contract into a financial tripwire for the broader transaction. In mid-2024, Puig’s purchase of an additional 5.4 percent stake implied a valuation of around €4 billion for the brand, illustrating the scale at play if the change-of-control mechanism were triggered in full.
Why Founder Compensation Negotiations Matter for Beauty M&A
The current standoff highlights a broader issue running through beauty brand acquisition strategies: how to align founder compensation with long-term corporate plans. Puig has built a reputation for keeping founders invested with minority stakes and performance-linked earn-outs. Similar models have been used for Dr. Barbara Sturm, Byredo and Dries Van Noten, aiming to preserve entrepreneurial drive inside a larger group structure. But the Charlotte Tilbury situation shows the downside when performance metrics, timelines and strategic exits collide. For Estée Lauder, assuming a large, opaque founder liability is a risk to deal economics and post-merger integration. For Tilbury, the merger window offers rare leverage to reset terms that may no longer reflect the brand’s perceived potential. As consolidation accelerates, founder compensation negotiations are becoming as critical as valuation in determining whether marquee beauty deals can close.
What a Puig–Estée Lauder Tie-Up Could Mean for Luxury Beauty
Despite the contractual tension, both Puig and Estée Lauder executives continue to describe the merger talks as ongoing, with no final agreement reached. Estée Lauder has reportedly engaged JPMorgan Chase & Co. to explore financing of around €5 billion to support a potential transaction involving Puig, signalling the strategic importance of the deal. A successful Charlotte Tilbury merger within a combined Puig–Estée Lauder portfolio would consolidate a powerful roster: from MAC Cosmetics and Clinique to Byredo, Jean Paul Gaultier and more. Such a move could reshape competitive dynamics in prestige colour cosmetics and skin care, concentrating creative talent, distribution muscle and marketing budgets under fewer corporate roofs. Whether that future materialises may hinge less on headline valuation and more on one founder’s satisfaction with her earn-out, a reminder that human-scale contracts can still redirect global beauty industry consolidation.